E-LIB Suche - Ergebnisse für: Hanna, Imad

1

Fevipiprant (QAW039) does not affect the pharmacokinetics o..:

Kulkarni, Swarupa ; Poller, Birk ; Drollmann, Anton...
Pulmonary Pharmacology & Therapeutics. 72 (2022) - p. 102097 , 2022

Link: https://doi.org/10.1016/..

2

Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibitio..:

Taskar, Kunal S. ; Yang, Xinning ; Neuhoff, Sibylle...
Clinical Pharmacology & Therapeutics. 112 (2022) 3 - p. 573-592 , 2022

Link: https://doi.org/10.1002/..

3

Predicting Oral Absorption for Compounds Outside the Rule o..:

Huth, Felix ; Domange, Norbert ; Poller, Birk...
Journal of Pharmaceutical Sciences. , 2021

Link: https://doi.org/10.1016/..

4

Genetic Diversity in Drug Transporters: Impact in African P..:

Rajman, Iris ; Knapp, Laura ; Hanna, Imad
Clinical and Translational Science. 13 (2020) 5 - p. 848-860 , 2020

Link: https://doi.org/10.1111/..

5

Intestinal Transporter-Associated Drug Absorption and Toxic..:

, In: Advances in Experimental Medicine and Biology; Drug Transporters in Drug Disposition, Effects and Toxicity,

Xue, Yaru ; Ma, Chenhui ; Hanna, Imad. - p. 361-405 , 2019

Link: https://doi.org/10.1007/..

6

Clinical Probes and Endogenous Biomarkers as Substrates for..:

Chu, Xiaoyan ; Liao, Mingxiang ; Shen, Hong...
Clinical Pharmacology & Therapeutics. 104 (2018) 5 - p. 836-864 , 2018

Link: https://doi.org/10.1002/..

7

Evaluation of Drug-Drug Interaction Potential Between Sacub..:

Lin, Wen ; Ji, Tao ; Einolf, Heidi...
Journal of Pharmaceutical Sciences. 106 (2017) 5 - p. 1439-1451 , 2017

Link: https://doi.org/10.1016/..

8

Clinical disposition, metabolism and in vitro drug–drug int..:

Flarakos, Jimmy ; Du, Yancy ; Gu, Helen...
Xenobiotica. 47 (2016) 8 - p. 682-696 , 2016

Link: https://doi.org/10.1080/..

9

Assessment of pharmacokinetic drug-drug interaction between..:

Mendonza, Anisha ; Hanna, Imad ; Meyers, Dan...
The Journal of Clinical Pharmacology. 56 (2015) 3 - p. 355-364 , 2015

Link: https://doi.org/10.1002/..

10

Evaluation of a potential transporter-mediated drug interac..:

Kulmatycki, Kenneth ; Hanna, Imad ; Meyers, Dan...
Int. Journal of Clinical Pharmacology and Therapeutics. 53 (2015) 5 - p. 345-355 , 2015

Link: https://doi.org/10.5414/..

11

Physiologically based pharmacokinetic modeling for assessin..:

Xia, Binfeng ; Barve, Avantika ; Heimbach, Tycho...
European Journal of Pharmaceutical Sciences. 63 (2014) - p. 103-112 , 2014

Link: https://doi.org/10.1016/..

12

Potent Nonimmunosuppressive Cyclophilin Inhibitors With Imp..:

Fu, Jiping ; Tjandra, Meiliana ; Becker, Christopher...
Journal of Medicinal Chemistry. 57 (2014) 20 - p. 8503-8516 , 2014

Link: https://doi.org/10.1021/..

13

Intestinal OATP1A2 inhibition as a potential mechanism for ..:

Rebello, Sam ; Zhao, Sally ; Hariry, Sam...
European Journal of Clinical Pharmacology. 68 (2011) 5 - p. 697-708 , 2011

Link: https://doi.org/10.1007/..

14

Role of Glutamic Acid 216 in Cytochrome P450 2D6 Substrate ..:

Guengerich, F. Peter ; Hanna, Imad H. ; Martin, Martha V..
Biochemistry. 42 (2003) 5 - p. 1245-1253 , 2003

Link: https://doi.org/10.1021/..

15

Diversity in the Oxidation of Substrates by Cytochrome P450..:

Guengerich, F. Peter ; Miller, Grover P. ; Hanna, Imad H....
Biochemistry. 41 (2002) 36 - p. 11025-11034 , 2002

Link: https://doi.org/10.1021/..